Pictet Asset Management
GMAB icon

Pictet Asset Management’s Genmab GMAB Stock Holding History

Pictet Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3M Sell
1,065,927
-11,544
-1% -$307K 0.03% 440
2026
Q1 		$28.9M Sell
1,077,471
-21,079
-2% -$632K 0.03% 420
2025
Q4 		$33.8M Buy
+1,098,550
New +$34.2M 0.03% 403

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Pictet Asset Management's GMAB Position: Q2 2026 in Review

Pictet Asset Management reduced its Genmab (GMAB) stake by 1.1% in Q2 2026, selling an estimated $307K and leaving 1,065,927 shares worth $29.3M. The position accounts for 0.03% of the portfolio, ranked #440.

Pictet Asset Management first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $33.8M in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Pictet Asset Management held 1,065,927 shares of Genmab worth $29.3M as of Q2 2026.
  • Pictet Asset Management sold 11,544 Genmab shares in Q2 2026, an estimated $307K.
  • Genmab made up 0.03% of Pictet Asset Management's portfolio in Q2 2026, its #440 holding.
  • Pictet Asset Management first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • Pictet Asset Management's Genmab position peaked at $33.8M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.